Head-to-head · Cost-Efficiency Index
Tablet Health vs Luvo Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Tablet Health
Cost-first shoppers who want an oral-tablet GLP-1 option at the lowest published tier ($179/mo), if you can tolerate no state-coverage list.
Visit Tablet HealthLuvo Health
Shoppers who want to read a complete, un-gated price list — compounded and brand, injection and tablet, at four commitment lengths — and who will do the four-week arithmetic before comparing it with a monthly rate.
Visit Luvo HealthThe verdict
Tablet Health takes it, leading the Cost-Efficiency Index 57 to 54. Tablet Health is a LegitScript-certified DTC telehealth platform selling compounded semaglutide and tirzepatide in both oral-tablet and injectable form, priced from $179/mo (oral semaglutide) to $299/mo (injectable tirzepatide). Luvo Health still earns a C — Shoppers who want to read a complete, un-gated price list — compounded and brand, injection and tablet, at four commitment lengths — and who will do the four-week arithmetic before comparing it with a monthly rate.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Tablet Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Tablet Health | Luvo Health |
|---|---|---|
| Cost-Efficiency Index | 57/100 | 54/100 |
| Semaglutide / mo | $199/mo (compounded) | $249 per 4 weeks (injection, compounded) |
| Tirzepatide / mo | $299/mo (compounded) | $339 per 4 weeks (injection, compounded) |
| Semaglutide / yr (modeled) | $2,388 | $2,988 |
| Tirzepatide / yr (modeled) | $3,588 | $4,068 |
| Coverage | Coverage not published | Not published |
| Oral / sublingual | Yes | Yes |
| Brand-name access | Compounded only | Yes |
| Rank here | #315 | #318 |
Tablet Health
57/100Where the value is
- LegitScript Certified — seal displayed on the site
- Offers both oral-tablet and injectable forms of semaglutide AND tirzepatide, four distinct SKUs
- Published per-product pricing rather than a single vague 'starting at' figure: $179-$299/mo across the four variants
The tradeoffs
- States served are not published anywhere on the accessible site — eligibility is only revealed by completing the intake quiz
- The homepage's 'Flat monthly pricing starting at $149' banner cannot be tied to any of the four listed $179-$299 tiers
Luvo Health
54/100Where the value is
- The whole price list is public and server-rendered at /pricing — 156 rows, every medication, both forms and all four commitment lengths — before any intake, quiz, login or email capture
- Both molecules and both routes are priced: semaglutide injection $249, semaglutide tablets $279 and tirzepatide injection $339 per 4 weeks, with no separate membership or visit line item on the price table
- Real brand-name access with real prices — Ozempic® $1,299 and Zepbound® $1,399 per 4 weeks — rather than a brand logo with no purchasable figure behind it
The tradeoffs
- Prices are billed every FOUR WEEKS, not monthly, so thirteen charges fall in a calendar year rather than twelve — this page's modeled 12-month figure is twelve four-week periods, which is 48 weeks, and the real annual cost is one period higher
- Two pages headline "Starting at $45/week", which is the 52-week prepay rate divided out — the weight-loss page discloses that it is billed annually and the medication page does not, so the same number is honest on one page and not on the other
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.